Identification of MyoD Interactome Using Tandem Affinity Purification Coupled to Mass Spectrometry.

Skeletal muscle terminal differentiation starts with the commitment of pluripotent mesodermal precursor cells to myoblasts. These cells have still the ability to proliferate or they can differentiate and fuse into multinucleated myotubes, which maturate further to form myofibers. Skeletal muscle terminal differentiation is orchestrated by the coordinated action of various transcription factors, in particular the members of the Muscle Regulatory Factors or MRFs (MyoD, Myogenin, Myf5, and MRF4), also called the myogenic bHLH transcription factors family. These factors cooperate with chromatin-remodeling complexes within elaborate transcriptional regulatory network to achieve skeletal myogenesis. In this, MyoD is considered the master myogenic transcription factor in triggering muscle terminal differentiation. This notion is strengthened by the ability of MyoD to convert non-muscle cells into skeletal muscle cells. Here we describe an approach used to identify MyoD protein partners in an exhaustive manner in order to elucidate the different factors involved in skeletal muscle terminal differentiation. The long-term aim is to understand the epigenetic mechanisms involved in the regulation of skeletal muscle genes, i.e., MyoD targets. MyoD partners are identified by using Tandem Affinity Purification (TAP-Tag) from a heterologous system coupled to mass spectrometry (MS) characterization, followed by validation of the role of relevant partners during skeletal muscle terminal differentiation. Aberrant forms of myogenic factors, or their aberrant regulation, are associated with a number of muscle disorders: congenital myasthenia, myotonic dystrophy, rhabdomyosarcoma and defects in muscle regeneration. As such, myogenic factors provide a pool of potential therapeutic targets in muscle disorders, both with regard to mechanisms that cause disease itself and regenerative mechanisms that can improve disease treatment. Thus, the detailed understanding of the intermolecular interactions and the genetic programs controlled by the myogenic factors is essential for the rational design of efficient therapies.

[1]  F. Dilworth,et al.  A KAP1 phosphorylation switch controls MyoD function during skeletal muscle differentiation , 2015, Genes & development.

[2]  P. Robin,et al.  The SWI/SNF Subunit/Tumor Suppressor BAF47/INI1 Is Essential in Cell Cycle Arrest upon Skeletal Muscle Terminal Differentiation , 2014, PloS one.

[3]  Le Cong,et al.  Multiplex Genome Engineering Using CRISPR/Cas Systems , 2013, Science.

[4]  Zhenguo Wu,et al.  Signal‐dependent incorporation of MyoD–BAF60c into Brg1‐based SWI/SNF chromatin‐remodelling complex , 2012, The EMBO journal.

[5]  W. K. Kok,et al.  Lysine methyltransferase G9a methylates the transcription factor MyoD and regulates skeletal muscle differentiation , 2012, Proceedings of the National Academy of Sciences.

[6]  P. L. Puri,et al.  SWI/SNF complexes, chromatin remodeling and skeletal myogenesis: it's time to exchange! , 2010, Experimental cell research.

[7]  Juri Rappsilber,et al.  The Protein Composition of Mitotic Chromosomes Determined Using Multiclassifier Combinatorial Proteomics , 2010, Cell.

[8]  L. Fritsch,et al.  The Core Binding Factor CBF Negatively Regulates Skeletal Muscle Terminal Differentiation , 2010, PloS one.

[9]  Annick Harel-Bellan,et al.  A subset of the histone H3 lysine 9 methyltransferases Suv39h1, G9a, GLP, and SETDB1 participate in a multimeric complex. , 2010, Molecular cell.

[10]  Brad T. Sherman,et al.  Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists , 2008, Nucleic acids research.

[11]  R. Losson,et al.  Differential Cooperation between Heterochromatin Protein HP1 Isoforms and MyoD in Myoblasts* , 2008, Journal of Biological Chemistry.

[12]  Brad T. Sherman,et al.  Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.

[13]  L. Fritsch,et al.  Post-translational modifications of histones H3 and H4 associated with the histone methyltransferases Suv39h1 and G9a , 2007, Genome Biology.

[14]  A. Harel-Bellan,et al.  The histone variant mH2A1.1 interferes with transcription by down-regulating PARP-1 enzymatic activity. , 2006, Genes & development.

[15]  L. Fritsch,et al.  Chromatin modification and muscle differentiation , 2006, Expert opinion on therapeutic targets.

[16]  S. Tapscott,et al.  The RNA helicases p68/p72 and the noncoding RNA SRA are coregulators of MyoD and skeletal muscle differentiation. , 2006, Developmental cell.

[17]  Y. Ohkawa,et al.  Skeletal muscle specification by myogenin and Mef2D via the SWI/SNF ATPase Brg1 , 2006, The EMBO journal.

[18]  S. Tapscott,et al.  The circuitry of a master switch: Myod and the regulation of skeletal muscle gene transcription , 2005, Development.

[19]  Zhenguo Wu,et al.  Akt binds prohibitin 2 and relieves its repression of MyoD and muscle differentiation , 2004, Journal of Cell Science.

[20]  A. Harel-Bellan,et al.  A Suv39h‐dependent mechanism for silencing S‐phase genes in differentiating but not in cycling cells , 2004, The EMBO journal.

[21]  A. Mal,et al.  MyoD is functionally linked to the silencing of a muscle-specific regulatory gene prior to skeletal myogenesis , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[22]  V. Ogryzko,et al.  Immunoaffinity purification of mammalian protein complexes. , 2003, Methods in enzymology.

[23]  E. Olson,et al.  Association of Class II Histone Deacetylases with Heterochromatin Protein 1: Potential Role for Histone Methylation in Control of Muscle Differentiation , 2002, Molecular and Cellular Biology.

[24]  M. Buckingham.  Skeletal muscle formation in vertebrates. , 2001, Current opinion in genetics & development.

[25]  P. L. Puri,et al.  Regulation of muscle regulatory factors by DNA‐binding, interacting proteins, and post‐transcriptional modifications , 2000, Journal of cellular physiology.

[26]  S. Tapscott,et al.  A conserved motif N-terminal to the DNA-binding domains of myogenic bHLH transcription factors mediates cooperative DNA binding with pbx-Meis1/Prep1. , 1999, Nucleic acids research.

[27]  H. Arnold,et al.  Muscle differentiation: more complexity to the network of myogenic regulators. , 1998, Current opinion in genetics & development.

[28]  N. Tanese.  Small-scale density gradient sedimentation to separate and analyze multiprotein complexes. , 1997, Methods.

[29]  B. Wold,et al.  Skeletal muscle determination and differentiation: story of a core regulatory network and its context. , 1996, Current opinion in cell biology.

[30]  E. Olson,et al.  Defining the regulatory networks for muscle development. , 1996, Current opinion in genetics & development.

[31]  M. Buckingham.  Skeletal muscle development and the role of the myogenic regulatory factors. , 1996, Biochemical Society transactions.

[32]  T. Braun,et al.  Targeted inactivation of myogenic factor genes reveals their role during mouse myogenesis: a review. , 1996, The International journal of developmental biology.

[33]  S. Tapscott,et al.  Activation of muscle-specific genes in pigment, nerve, fat, liver, and fibroblast cell lines by forced expression of MyoD. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[34]  S. Tapscott,et al.  MyoD1: a nuclear phosphoprotein requiring a Myc homology region to convert fibroblasts to myoblasts. , 1988, Science.

[35]  H. Weintraub,et al.  Expression of a single transfected cDNA converts fibroblasts to myoblasts , 1987, Cell.

[36]  Harold Weintraub,et al.  Transfection of a DNA locus that mediates the conversion of 10T1 2 fibroblasts to myoblasts , 1986, Cell.